Literature DB >> 7924678

Quantitative analysis of chromosome in situ hybridization signal in paraffin-embedded tissue sections.

K Dhingra1, N Sneige, T K Pandita, D A Johnston, J S Lee, K Emami, G N Hortobagyi, W N Hittelman.   

Abstract

Interphase cytogenetic analysis using chromosome-specific probes is increasingly being used to detect chromosomal aberrations on paraffin-embedded tissue sections. However, quantitative analysis of the hybridization signal is confounded by the nuclear slicing that occurs during sectioning. To determine the sensitivity and accuracy of chromosome in situ hybridization for detecting numerical chromosomal aberrations on paraffin-embedded sections, in situ hybridization was performed on sections derived from mixtures of cell populations with known frequencies of numerical chromosomal aberrations and the Chromosome Index (CI) was calculated (i.e., total number of signal spots/number of nuclei counted) as a quantitative measure of chromosome copy number. The presence of 25% or more monosomic or tetrasomic cells in a given population was easily detected as a change in CI (P < 0.05). Lower degrees of polysomy could be detected as a small percentage of nuclear fragments with > 2 signal spots. The CI was not significantly influenced by a change in section thickness from 4 to 8 microM, by an increase in cell size from 478 to 986 microM3, or by the choice of detection method (fluorescence vs. conventional bright-field microscopy). Comparative analysis of touch preparations and tissue sections from the corresponding breast tumors showed that CI accurately reflects the average copy number of chromosomes in intact nuclei and may actually be superior to in situ hybridization on whole nuclei for the detection of numerical chromosomal changes in defined histologic areas. This method is thus a sensitive and accurate means of studying genetic changes in premalignant and malignant tissue, and of assessing the genetic changes associated with specific phenotypes.

Entities:  

Mesh:

Year:  1994        PMID: 7924678     DOI: 10.1002/cyto.990160203

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  7 in total

1.  Liver metastatic ability of human melanoma cell line is associated with losses of chromosomes 4, 9p21-pter and 10p.

Authors:  Z Adám; R Adány; A Ladányi; J Tímár; M Balázs
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Interphase in situ hybridization to disaggregated and intact tissue specimens of prostatic adenocarcinomas.

Authors:  J C Alers; P J Krijtenburg; K J Vissers; S K Krishnadath; F T Bosman; H van Dekken
Journal:  Histochem Cell Biol       Date:  1995-12       Impact factor: 4.304

3.  Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections.

Authors:  T Chen; K Dhingra; A Sahin; N Sneige; G Hortobagyi; C M Aldaz
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Quantitative analysis of numerical chromosome aberrations in various morphological types of colorectal carcinomas.

Authors:  A Nanashima; Y Tagawa; M Morinaga; H Kusano; T Nakagoe; H Ayabe
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

5.  Cytogenetic and immunohistochemical study of 42 pigmented microcystic chromophobe renal cell carcinoma (PMChRCC).

Authors:  Francisco Javier Queipo Gutiérrez; Ángel Panizo; Antonio Tienza; Irene Rodriguez; Jesús Javier Sola; Jordi Temprana-Salvador; Inés de Torres; Javier Pardo-Mindán
Journal:  Virchows Arch       Date:  2018-06-21       Impact factor: 4.064

6.  Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation.

Authors:  M T Sandinha; M A Farquharson; F Roberts
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

7.  Increasing genome instability in adrenocortical carcinoma progression with involvement of chromosomes 3, 9 and X at the adenoma stage.

Authors:  A J Russell; J Sibbald; H Haak; W N Keith; A M McNicol
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.